Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Mass Spec Imaging from Protea and More


Protea Biosciences this week introduced its Mass Spec Imaging Center, a dedicated facility for mass spec-based imaging projects featuring instrumentation including the company's LAESI DP-1000 system.

The center specializes in distribution profiling of biomolecules in tissues, biofilms, and living populations including cell cultures, bacteria, and fungal colonies, the company said.

Nonlinear Dynamics has introduced a new application, Progenesis ClearSpec, as part of its Progenesis LC-MS software package.

The application deisotopes and charge deconvolutes thousands of high-resolution MS/MS spectra in seconds to aid in analysis of MS/MS data, the company said.

Thermo Fisher Scientific has introduced its MYECL imager for capture and analysis of protein and nucleic acid gels and western blots.

The imager uses charge-coupled device camera technology to double the sensitivity of conventional X-ray film and improve the dynamic range 10-fold, the company said.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.